Detection of DNA damage in individual cells
NorGenoTech is a biomedical technology company providing efficient analysis of DNA damage.
We develop equipment, carry out research projects and offer services and training courses.
At the heart of our technology is the comet assay, which has potential as a diagnostic tool in personalized medicine and is already widely used in human bio-monitoring and for industrial testing of chemicals and drugs.
We have developed a high throughput, integrated, user-friendly DNA damage testing facility. Hospitals, research labs, chemical and pharma industries and regulators form our present and future customer base.
Examples of projects – explore more in our updates section
- EU-funded project NANO2FILM “Targeted multiplexed lipid nanocarriers against drug-resistant bacterial bioFILM” (NANO2FILM): financial beneficiary contributing expertise in safety assessment of innovative class of nanomedicine (2025-2028)
- Marie Sklodowska-Curie Doctoral Network Project ‘NANAQUA’: Nanotechnology-enabled water treatment /WP leader and PhD promoter and Beneficiary with financial responsibility /EC public funding (2025-2029)
- Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) project ‘CompSafeNano’: NanoInformatics Approaches for Safe-by-Design / WP leader and Beneficiary with financial responsibility / EC public funding (2022-2026)
- Industrial PhD project ‘DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients’ / PhD supervisor, Project Manager / Pubic funding from NFR and private funding (50/50)
- EEA and Norway Grants project ‘Theranostic Exosomes in Personalized Cancer Nanomedicine – TEPCAN’ (Funding No. TEPCAN/0057/2019-00) / Project partner / EC public funding (80%) and private funding (20%)
Examples of products – explore our products
